Blood and Immunity — MCQs

Q: What is the inheritance pattern of the ABO blood group system and the HLA system?

Codominant. ### Explanation **Correct Option: D (Codominant)** The ABO blood group and the Human Leukocyte Antigen (HLA) system are classic examples of **codominance**. In codominance, both alleles in a heterozygous individual are fully expressed, and neither masks the other. * **ABO System:** The $I^A$ and $I^B$ alleles are codominant. If an individual inherits $I^A$ from one parent and $I^B$ from the other, their phenotype is AB, expressing both A and B antigens on the RBC surface. (Note: Both $I^A$ and $I^B$ are dominant over the $i$ allele). * **HLA System:** HLA genes (located on Chromosome 6) are the most polymorphic genes in humans. An individual expresses HLA antigens from both maternal and paternal haplotypes simultaneously on the cell surface. This is critical for immune recognition and organ transplant matching. **Why other options are incorrect:** * **A. Pseudodominance:** This occurs when a recessive allele is expressed because the dominant allele is missing (e.g., due to deletion), commonly seen in X-linked disorders in males. * **B & C. Autosomal Dominant/Recessive:** These follow Mendelian patterns where one allele masks the other. In ABO, while A and B are dominant over O, they do not mask each other, making "Codominant" the more specific and accurate description. **High-Yield Facts for NEET-PG:** 1. **Multiple Allelism:** The ABO system is also an example of multiple allelism (three alleles: A, B, and O). 2. **Bombay Phenotype:** A rare condition where the H-substance is missing; these individuals phenotypically appear as Type O regardless of their genotype. 3. **HLA Association:** HLA-B27 is strongly associated with Ankylosing Spondylitis; HLA-DR3/DR4 is associated with Type 1 Diabetes Mellitus. 4. **Chromosome 9:** The locus for the ABO gene is on the long arm of Chromosome 9.

Q: What is the first cell in the development of red blood cells?

Proerythroblast. **Explanation:** The process of red blood cell formation, known as **erythropoiesis**, occurs in the bone marrow. It begins with a multipotent hematopoietic stem cell, which differentiates into a **Proerythroblast** (also called a Pronormoblast). **Why Proerythroblast is correct:** The Proerythroblast is the **first morphologically identifiable committed precursor** of the erythroid series. It is a large cell with a big nucleus, visible nucleoli, and a thin rim of basophilic cytoplasm. Once a stem cell differentiates into a proerythroblast, it is "committed" to becoming a mature erythrocyte. **Analysis of Incorrect Options:** * **Basophilic erythroblast (Early Normoblast):** This is the second stage. It is smaller than the proerythroblast and shows intense cytoplasmic basophilia due to an accumulation of RNA for hemoglobin synthesis. * **Intermediate normoblast (Polychromatophilic erythroblast):** This is the third stage. It is characterized by a "checkered" nucleus and a cytoplasm that appears grayish/purple because it contains both basic RNA and acidic hemoglobin. * **Reticulocyte:** This is the penultimate stage, occurring after the nucleus is extruded (at the orthochromatic stage). It is an immature RBC that stays in the marrow for 1–2 days before entering the peripheral circulation. **NEET-PG High-Yield Pearls:** 1. **Hemoglobin synthesis** begins in the **Proerythroblast** stage, but becomes visible (morphologically detectable) in the **Intermediate Normoblast** stage. 2. The **nucleus is extruded** at the **Orthochromatic Normoblast** (Late Normoblast) stage. 3. **Reticulocyte count** is the best clinical indicator of effective erythropoiesis in the bone marrow. 4. **Erythropoietin (EPO)** primarily acts on the CFU-E (Colony Forming Unit-Erythroid) to stimulate the production of proerythroblasts.

Q: Which of the following is responsible for the adhesion of platelets to the vessel wall?

Von Willebrand factor. **Explanation:** The correct answer is **Von Willebrand factor (vWF)**. Platelet plug formation occurs in three distinct stages: Adhesion, Activation, and Aggregation. 1. **Why vWF is correct:** When a blood vessel is injured, the subendothelial collagen is exposed. Platelets cannot bind directly to collagen under high-shear stress (like in arteries). **vWF** acts as a molecular bridge; one end binds to the exposed **subendothelial collagen**, and the other end binds to the **Glycoprotein Ib (GpIb)** receptor on the platelet surface. This specific interaction is responsible for **platelet adhesion**. 2. **Why the other options are incorrect:** * **Factor IX:** This is a component of the intrinsic pathway of the coagulation cascade. Its deficiency leads to Hemophilia B (Christmas disease). It is involved in secondary hemostasis (clotting), not primary platelet adhesion. * **Fibrinogen:** This is responsible for **platelet aggregation**. Fibrinogen binds to the **GpIIb/IIIa** receptors on adjacent platelets, linking them together to form a plug. * **Fibronectin:** While fibronectin is present in the extracellular matrix and plasma and plays a minor role in cell-matrix interactions, it is not the primary mediator of initial platelet adhesion to the vessel wall. **High-Yield Clinical Pearls for NEET-PG:** * **Bernard-Soulier Syndrome:** A deficiency of the **GpIb** receptor, leading to defective adhesion (characterized by giant platelets and thrombocytopenia). * **Von Willebrand Disease (vWD):** The most common inherited bleeding disorder; it results in defective adhesion due to a deficiency or dysfunction of vWF. * **Glanzmann Thrombasthenia:** A deficiency of the **GpIIb/IIIa** receptor, leading to defective **aggregation**. * **vWF Source:** It is synthesized in endothelial cells (stored in **Weibel-Palade bodies**) and megakaryocytes (stored in **α-granules** of platelets).

Q: What is the predominant immunoglobulin found in saliva?

IgA. **Explanation:** **Correct Option: A (IgA)** Immunoglobulin A (IgA) is the predominant antibody found in seromucous secretions, including **saliva**, tears, colostrum, and gastrointestinal/respiratory secretions. In these fluids, it exists primarily as **Secretory IgA (sIgA)**, which is a dimer. It contains a **J-chain** (joining chain) and a **secretory component** that protects the antibody from degradation by proteolytic enzymes in the harsh environments of the gut and mouth. Its primary function is "immune exclusion," preventing the attachment of pathogens to mucosal surfaces. **Why other options are incorrect:** * **IgD:** Primarily found on the surface of B-lymphocytes where it acts as an antigen receptor. It is present in only trace amounts in serum and secretions. * **IgE:** Involved in type I hypersensitivity (allergic) reactions and defense against helminthic parasites. It is found in very low concentrations in the blood and is typically bound to mast cells and basophils. * **IgG:** The most abundant immunoglobulin in the **serum** (approx. 75-80%) and the only one that crosses the placenta. While it can be found in saliva via gingival crevicular fluid, it is not the predominant type. **High-Yield NEET-PG Pearls:** * **Structure:** IgA is a monomer in serum but a **dimer** in secretions. * **Selective IgA Deficiency:** The most common primary immunodeficiency; patients often present with recurrent sinopulmonary and GI infections. * **Breast Milk:** IgA is the most abundant antibody in colostrum, providing passive immunity to the neonate's gut. * **Half-life:** IgG has the longest half-life (approx. 23 days), making it the mainstay of secondary immune responses.

Q: What is the fluid component of blood?

Plasma. **Explanation:** **Why Plasma is the Correct Answer:** Blood is a specialized connective tissue consisting of formed elements (RBCs, WBCs, and platelets) suspended in a liquid extracellular matrix called **Plasma**. Plasma constitutes approximately 55% of the total blood volume. It is composed of 91-92% water and 8-9% solids (primarily plasma proteins like albumin, globulins, and fibrinogen, along with electrolytes and nutrients). Crucially, plasma is the fluid obtained when blood is collected with an **anticoagulant** and centrifuged; it retains all clotting factors, including fibrinogen. **Analysis of Incorrect Options:** * **B. Serum:** Serum is the fluid that remains after blood has clotted. It is essentially **Plasma minus Fibrinogen** and clotting factors (II, V, VIII, and XIII). While it is a fluid, it is not the physiological component circulating in the vessels. * **C. Water:** While water is the primary solvent in plasma (91%), it is not the "fluid component" itself, as plasma contains vital proteins and solutes necessary for osmotic pressure and transport. * **D. Tissue Fluid (Interstitial Fluid):** This is the fluid that bathes the cells outside the vascular system. It is formed by the filtration of plasma across capillary walls but lacks the high protein concentration found in blood. **NEET-PG High-Yield Pearls:** * **Formula to remember:** Serum = Plasma – Clotting Factors (Fibrinogen). * **Albumin:** The most abundant plasma protein; it is the primary determinant of **Plasma Oncotic Pressure** (approx. 25-28 mmHg). * **Hematocrit (Packed Cell Volume):** The percentage of total blood volume occupied by RBCs (Normal: ~45%). * **Plasmapheresis:** A clinical procedure used to remove specific antibodies from the plasma in conditions like Guillain-Barré Syndrome or Myasthenia Gravis.

Q: Serum is blood plasma without which of the following components?

Fibrinogen. **Explanation:** The fundamental difference between plasma and serum lies in the process of **coagulation**. **1. Why Fibrinogen is the correct answer:** Plasma is the liquid, cell-free part of blood that has been treated with anti-coagulants. However, when blood is allowed to clot naturally, the soluble protein **fibrinogen** is converted into an insoluble mesh of **fibrin** to form the clot. **Serum** is the fluid that remains after this clotting process is complete. Therefore, serum is essentially "plasma minus fibrinogen and other clotting factors" (Factors II, V, VIII, and XIII are also consumed during the process). **2. Analysis of Incorrect Options:** * **A & C (Blood cells & Lymphocytes):** Both plasma and serum are acellular fluids. Blood cells (RBCs, WBCs/Lymphocytes, and Platelets) are removed from plasma via centrifugation and are trapped within the clot in serum. Thus, the absence of cells does not distinguish serum from plasma. * **D (Plasma colloids):** These include proteins like albumin and globulins. These remain present in both plasma and serum as they are not consumed during the coagulation cascade. **3. NEET-PG High-Yield Pearls:** * **Formula to remember:** Serum = Plasma – Clotting Factors (primarily Fibrinogen). * **Electrophoresis:** Serum is the preferred specimen for protein electrophoresis because the absence of the fibrinogen peak (which lies between the beta and gamma regions) allows for a clearer interpretation of other protein fractions. * **Clinical Use:** Serum is used for most serological tests and clinical chemistry (e.g., electrolytes, liver function tests) because it does not contain anticoagulants that might interfere with chemical reactions.

Blood and Immunity Indian Medical PG Practice Questions and MCQs

Question 1: What is the inheritance pattern of the ABO blood group system and the HLA system?

A. Pseudodominance
B. Autosomal dominant
C. Autosomal recessive
D. Codominant (Correct Answer)

Explanation: ### Explanation **Correct Option: D (Codominant)** The ABO blood group and the Human Leukocyte Antigen (HLA) system are classic examples of **codominance**. In codominance, both alleles in a heterozygous individual are fully expressed, and neither masks the other. * **ABO System:** The $I^A$ and $I^B$ alleles are codominant. If an individual inherits $I^A$ from one parent and $I^B$ from the other, their phenotype is AB, expressing both A and B antigens on the RBC surface. (Note: Both $I^A$ and $I^B$ are dominant over the $i$ allele). * **HLA System:** HLA genes (located on Chromosome 6) are the most polymorphic genes in humans. An individual expresses HLA antigens from both maternal and paternal haplotypes simultaneously on the cell surface. This is critical for immune recognition and organ transplant matching. **Why other options are incorrect:** * **A. Pseudodominance:** This occurs when a recessive allele is expressed because the dominant allele is missing (e.g., due to deletion), commonly seen in X-linked disorders in males. * **B & C. Autosomal Dominant/Recessive:** These follow Mendelian patterns where one allele masks the other. In ABO, while A and B are dominant over O, they do not mask each other, making "Codominant" the more specific and accurate description. **High-Yield Facts for NEET-PG:** 1. **Multiple Allelism:** The ABO system is also an example of multiple allelism (three alleles: A, B, and O). 2. **Bombay Phenotype:** A rare condition where the H-substance is missing; these individuals phenotypically appear as Type O regardless of their genotype. 3. **HLA Association:** HLA-B27 is strongly associated with Ankylosing Spondylitis; HLA-DR3/DR4 is associated with Type 1 Diabetes Mellitus. 4. **Chromosome 9:** The locus for the ABO gene is on the long arm of Chromosome 9.

Question 2: All of the following are functions of the spleen EXCEPT?

A. Clearance of damaged or aged red blood cells (RBCs) from the blood.
B. Extramedullary site for hematopoiesis and recycling iron.
C. Initiation of adaptive immune response from filtration of lymph. (Correct Answer)
D. Clearance of encapsulated bacteria from the bloodstream.

Explanation: ### Explanation The correct answer is **C. Initiation of adaptive immune response from filtration of lymph.** The spleen is often described as a "giant lymph node," but there is a critical anatomical difference: **the spleen filters blood, not lymph.** Lymph nodes are responsible for filtering interstitial fluid (lymph) via afferent lymphatic vessels. The spleen lacks afferent lymphatics; instead, it samples antigens directly from the systemic circulation via the splenic artery. #### Analysis of Options: * **Option A (Correct Function):** The splenic sinusoids and the "pitting" mechanism in the Red Pulp act as a biological filter, removing senescent, rigid, or damaged RBCs (Culling). * **Option B (Correct Function):** During fetal development (months 3–7), the spleen is a primary hematopoietic organ. In adults, it can resume this role (extramedullary hematopoiesis) in conditions like myelofibrosis. It also recycles iron from hemoglobin via splenic macrophages. * **Option D (Correct Function):** The White Pulp contains B-cells and T-cells. Splenic macrophages and antibodies are essential for opsonizing and clearing **encapsulated organisms** (e.g., *S. pneumoniae, H. influenzae, N. meningitidis*). #### High-Yield Clinical Pearls for NEET-PG: * **Asplenia/Splenectomy:** Patients are at high risk for **OPSI (Overwhelming Post-Splenectomy Infection)**. Vaccination against encapsulated bacteria is mandatory (ideally 2 weeks before elective surgery). * **Howell-Jolly Bodies:** These are nuclear remnants in RBCs normally removed by the spleen; their presence on a peripheral smear is a hallmark of splenic dysfunction or asplenia. * **Pitting:** The spleen’s ability to remove inclusions (like malaria parasites or Heinz bodies) from RBCs without destroying the cell itself.

Question 3: What is the first cell in the development of red blood cells?

A. Proerythroblast (Correct Answer)
B. Intermediate normoblast
C. Reticulocyte
D. Basophilic erythroblast

Explanation: **Explanation:** The process of red blood cell formation, known as **erythropoiesis**, occurs in the bone marrow. It begins with a multipotent hematopoietic stem cell, which differentiates into a **Proerythroblast** (also called a Pronormoblast). **Why Proerythroblast is correct:** The Proerythroblast is the **first morphologically identifiable committed precursor** of the erythroid series. It is a large cell with a big nucleus, visible nucleoli, and a thin rim of basophilic cytoplasm. Once a stem cell differentiates into a proerythroblast, it is "committed" to becoming a mature erythrocyte. **Analysis of Incorrect Options:** * **Basophilic erythroblast (Early Normoblast):** This is the second stage. It is smaller than the proerythroblast and shows intense cytoplasmic basophilia due to an accumulation of RNA for hemoglobin synthesis. * **Intermediate normoblast (Polychromatophilic erythroblast):** This is the third stage. It is characterized by a "checkered" nucleus and a cytoplasm that appears grayish/purple because it contains both basic RNA and acidic hemoglobin. * **Reticulocyte:** This is the penultimate stage, occurring after the nucleus is extruded (at the orthochromatic stage). It is an immature RBC that stays in the marrow for 1–2 days before entering the peripheral circulation. **NEET-PG High-Yield Pearls:** 1. **Hemoglobin synthesis** begins in the **Proerythroblast** stage, but becomes visible (morphologically detectable) in the **Intermediate Normoblast** stage. 2. The **nucleus is extruded** at the **Orthochromatic Normoblast** (Late Normoblast) stage. 3. **Reticulocyte count** is the best clinical indicator of effective erythropoiesis in the bone marrow. 4. **Erythropoietin (EPO)** primarily acts on the CFU-E (Colony Forming Unit-Erythroid) to stimulate the production of proerythroblasts.

Question 4: The biconcave shape of RBC is useful for all the following functions EXCEPT:

A. Allows considerable alteration in cell volume
B. Increasing surface area for diffusion (Correct Answer)
C. Resisting hemolysis
D. Passing easily through smaller capillaries

Explanation: The biconcave shape of the Red Blood Cell (RBC) is a specialized structural adaptation designed for flexibility and volume management rather than maximizing surface area. ### **Explanation of the Correct Answer** **Option B (Increasing surface area for diffusion)** is the correct answer because it is a common misconception. Mathematically, a **sphere** has the minimum surface area for a given volume, while a **flat disc** or complex shape has more. However, the biconcave shape is *not* the most efficient shape for maximizing surface area; a thin, flat sheet or a highly folded membrane would provide more area for gas exchange. The primary evolutionary "goal" of the biconcave shape is to provide a high **surface-area-to-volume ratio**, which allows for significant cell deformation and volume changes without stretching the membrane. ### **Analysis of Other Options** * **Option A & C:** The biconcave shape provides "excess" membrane. This allows the RBC to undergo **considerable alteration in cell volume** (swelling in hypotonic solutions) without rupturing. Because the membrane isn't under tension in its resting state, it can expand into a spherical shape before bursting, thereby **resisting hemolysis**. * **Option D:** RBCs (7.5 µm) must pass through splenic sinusoids and capillaries as small as 3 µm. The biconcave shape allows the cell to fold and deform easily (**high deformability**), facilitating passage through narrow microvasculature. ### **High-Yield Clinical Pearls for NEET-PG** * **Hereditary Spherocytosis:** A defect in membrane proteins (Ankyrin/Spectrin) causes RBCs to lose their biconcave shape and become spherical. These cells have the *lowest* surface-area-to-volume ratio, are fragile, and are easily destroyed in the spleen. * **Average RBC Diameter:** 7.5 µm (Thickness: 2 µm at periphery, 1 µm at center). * **Rouleaux Formation:** The biconcave shape facilitates the "stacking" of RBCs, seen in states of high ESR (e.g., chronic inflammation).

Question 5: Which of the following is responsible for the adhesion of platelets to the vessel wall?

A. Von Willebrand factor (Correct Answer)
B. Factor IX
C. Fibrinogen
D. Fibronectin

Explanation: **Explanation:** The correct answer is **Von Willebrand factor (vWF)**. Platelet plug formation occurs in three distinct stages: Adhesion, Activation, and Aggregation. 1. **Why vWF is correct:** When a blood vessel is injured, the subendothelial collagen is exposed. Platelets cannot bind directly to collagen under high-shear stress (like in arteries). **vWF** acts as a molecular bridge; one end binds to the exposed **subendothelial collagen**, and the other end binds to the **Glycoprotein Ib (GpIb)** receptor on the platelet surface. This specific interaction is responsible for **platelet adhesion**. 2. **Why the other options are incorrect:** * **Factor IX:** This is a component of the intrinsic pathway of the coagulation cascade. Its deficiency leads to Hemophilia B (Christmas disease). It is involved in secondary hemostasis (clotting), not primary platelet adhesion. * **Fibrinogen:** This is responsible for **platelet aggregation**. Fibrinogen binds to the **GpIIb/IIIa** receptors on adjacent platelets, linking them together to form a plug. * **Fibronectin:** While fibronectin is present in the extracellular matrix and plasma and plays a minor role in cell-matrix interactions, it is not the primary mediator of initial platelet adhesion to the vessel wall. **High-Yield Clinical Pearls for NEET-PG:** * **Bernard-Soulier Syndrome:** A deficiency of the **GpIb** receptor, leading to defective adhesion (characterized by giant platelets and thrombocytopenia). * **Von Willebrand Disease (vWD):** The most common inherited bleeding disorder; it results in defective adhesion due to a deficiency or dysfunction of vWF. * **Glanzmann Thrombasthenia:** A deficiency of the **GpIIb/IIIa** receptor, leading to defective **aggregation**. * **vWF Source:** It is synthesized in endothelial cells (stored in **Weibel-Palade bodies**) and megakaryocytes (stored in **α-granules** of platelets).

Question 6: What is the predominant immunoglobulin found in saliva?

A. IgA (Correct Answer)
B. IgD
C. IgE
D. IgG

Explanation: **Explanation:** **Correct Option: A (IgA)** Immunoglobulin A (IgA) is the predominant antibody found in seromucous secretions, including **saliva**, tears, colostrum, and gastrointestinal/respiratory secretions. In these fluids, it exists primarily as **Secretory IgA (sIgA)**, which is a dimer. It contains a **J-chain** (joining chain) and a **secretory component** that protects the antibody from degradation by proteolytic enzymes in the harsh environments of the gut and mouth. Its primary function is "immune exclusion," preventing the attachment of pathogens to mucosal surfaces. **Why other options are incorrect:** * **IgD:** Primarily found on the surface of B-lymphocytes where it acts as an antigen receptor. It is present in only trace amounts in serum and secretions. * **IgE:** Involved in type I hypersensitivity (allergic) reactions and defense against helminthic parasites. It is found in very low concentrations in the blood and is typically bound to mast cells and basophils. * **IgG:** The most abundant immunoglobulin in the **serum** (approx. 75-80%) and the only one that crosses the placenta. While it can be found in saliva via gingival crevicular fluid, it is not the predominant type. **High-Yield NEET-PG Pearls:** * **Structure:** IgA is a monomer in serum but a **dimer** in secretions. * **Selective IgA Deficiency:** The most common primary immunodeficiency; patients often present with recurrent sinopulmonary and GI infections. * **Breast Milk:** IgA is the most abundant antibody in colostrum, providing passive immunity to the neonate's gut. * **Half-life:** IgG has the longest half-life (approx. 23 days), making it the mainstay of secondary immune responses.

Question 7: Which of the following does NOT occur during hemostasis?

A. Vasospasm of the blood vessel
B. Platelet plug formation
C. Dissolution of the clot by plasmin
D. None of the above (Correct Answer)

Explanation: ### Explanation The correct answer is **None of the above** because all the processes listed (Vasospasm, Platelet plug formation, and Clot dissolution) are integral components of the physiological process of **Hemostasis**. Hemostasis is the body's mechanism to stop bleeding and maintain blood in a fluid state within the vessels. It occurs in four distinct but overlapping stages: 1. **Vascular Spasm (Vasoconstriction):** Immediately after injury, smooth muscles in the vessel wall contract. This is mediated by local myogenic spasms, nervous reflexes, and humoral factors like **Thromboxane A2 (TXA2)** and **Serotonin** released from platelets. This reduces blood flow to the injured area. 2. **Primary Hemostasis (Platelet Plug Formation):** Platelets adhere to exposed sub-endothelial collagen (via von Willebrand factor), undergo activation, and aggregate to form a temporary, friable "primary platelet plug." 3. **Secondary Hemostasis (Blood Coagulation):** The coagulation cascade is activated, leading to the conversion of soluble fibrinogen into insoluble **fibrin** threads, which stabilize the platelet plug into a solid clot. 4. **Tertiary Hemostasis (Fibrinolysis):** Once the vessel wall is repaired, the clot must be removed to restore normal blood flow. **Plasmin** (derived from plasminogen) digests the fibrin meshwork, leading to clot dissolution. **Why other options are incorrect:** * **Option A & B:** These are the initial steps of hemostasis. * **Option C:** Fibrinolysis (clot dissolution) is considered the final stage of the hemostatic process to prevent permanent vessel occlusion. **High-Yield NEET-PG Pearls:** * **Rate-limiting step of coagulation:** The formation of **Prothrombin Activator**. * **Vitamin K-dependent factors:** II, VII, IX, X, Protein C, and Protein S. * **Antithrombin III:** The most important natural anticoagulant; its action is potentiated by Heparin. * **Fibrin Degradation Products (FDPs):** D-dimer is a specific marker for fibrinolysis, used clinically to rule out DVT or PE.

Question 8: What is the fluid component of blood?

A. Plasma (Correct Answer)
B. Serum
C. Water
D. Tissue fluid

Explanation: **Explanation:** **Why Plasma is the Correct Answer:** Blood is a specialized connective tissue consisting of formed elements (RBCs, WBCs, and platelets) suspended in a liquid extracellular matrix called **Plasma**. Plasma constitutes approximately 55% of the total blood volume. It is composed of 91-92% water and 8-9% solids (primarily plasma proteins like albumin, globulins, and fibrinogen, along with electrolytes and nutrients). Crucially, plasma is the fluid obtained when blood is collected with an **anticoagulant** and centrifuged; it retains all clotting factors, including fibrinogen. **Analysis of Incorrect Options:** * **B. Serum:** Serum is the fluid that remains after blood has clotted. It is essentially **Plasma minus Fibrinogen** and clotting factors (II, V, VIII, and XIII). While it is a fluid, it is not the physiological component circulating in the vessels. * **C. Water:** While water is the primary solvent in plasma (91%), it is not the "fluid component" itself, as plasma contains vital proteins and solutes necessary for osmotic pressure and transport. * **D. Tissue Fluid (Interstitial Fluid):** This is the fluid that bathes the cells outside the vascular system. It is formed by the filtration of plasma across capillary walls but lacks the high protein concentration found in blood. **NEET-PG High-Yield Pearls:** * **Formula to remember:** Serum = Plasma – Clotting Factors (Fibrinogen). * **Albumin:** The most abundant plasma protein; it is the primary determinant of **Plasma Oncotic Pressure** (approx. 25-28 mmHg). * **Hematocrit (Packed Cell Volume):** The percentage of total blood volume occupied by RBCs (Normal: ~45%). * **Plasmapheresis:** A clinical procedure used to remove specific antibodies from the plasma in conditions like Guillain-Barré Syndrome or Myasthenia Gravis.

Question 9: Serum is blood plasma without which of the following components?

A. Blood cells
B. Fibrinogen (Correct Answer)
C. Lymphocytes
D. Plasma colloids

Explanation: **Explanation:** The fundamental difference between plasma and serum lies in the process of **coagulation**. **1. Why Fibrinogen is the correct answer:** Plasma is the liquid, cell-free part of blood that has been treated with anti-coagulants. However, when blood is allowed to clot naturally, the soluble protein **fibrinogen** is converted into an insoluble mesh of **fibrin** to form the clot. **Serum** is the fluid that remains after this clotting process is complete. Therefore, serum is essentially "plasma minus fibrinogen and other clotting factors" (Factors II, V, VIII, and XIII are also consumed during the process). **2. Analysis of Incorrect Options:** * **A & C (Blood cells & Lymphocytes):** Both plasma and serum are acellular fluids. Blood cells (RBCs, WBCs/Lymphocytes, and Platelets) are removed from plasma via centrifugation and are trapped within the clot in serum. Thus, the absence of cells does not distinguish serum from plasma. * **D (Plasma colloids):** These include proteins like albumin and globulins. These remain present in both plasma and serum as they are not consumed during the coagulation cascade. **3. NEET-PG High-Yield Pearls:** * **Formula to remember:** Serum = Plasma – Clotting Factors (primarily Fibrinogen). * **Electrophoresis:** Serum is the preferred specimen for protein electrophoresis because the absence of the fibrinogen peak (which lies between the beta and gamma regions) allows for a clearer interpretation of other protein fractions. * **Clinical Use:** Serum is used for most serological tests and clinical chemistry (e.g., electrolytes, liver function tests) because it does not contain anticoagulants that might interfere with chemical reactions.

Question 10: Which of the following can prevent the coagulation of blood?

A. Calcium oxalate
B. Sodium citrate (Correct Answer)
C. Sodium iodide
D. Potassium chloride

Explanation: ### Explanation **Underlying Concept: The Role of Calcium in Coagulation** Calcium ions ($Ca^{2+}$) are essential for the blood coagulation cascade, acting as **Factor IV**. They are required for the activation of several factors (IX, X, II, VII) and the formation of the prothrombin activator complex. If free calcium ions are removed or sequestered from the blood, the coagulation cascade is halted. **Why Sodium Citrate is Correct:** Sodium citrate is a **chelating agent**. When added to blood, it reacts with ionized calcium to form **calcium citrate**, a non-ionized, soluble complex. By "sequestering" the free calcium ions, sodium citrate effectively prevents the conversion of prothrombin to thrombin, thereby inhibiting clot formation. **Analysis of Incorrect Options:** * **Calcium Oxalate (A):** While oxalate ions *can* prevent coagulation by precipitating calcium as insoluble calcium oxalate, **Calcium oxalate** itself already contains calcium. Adding it would not remove free calcium from the blood; instead, it is the end-product of the reaction when *Sodium/Potassium Oxalate* is used as an anticoagulant. * **Sodium Iodide (C) & Potassium Chloride (D):** These are simple salts that do not have chelating or precipitating properties regarding calcium ions. They do not interfere with the biochemical pathways of the coagulation cascade. **Clinical Pearls for NEET-PG:** * **In Vitro vs. In Vivo:** Sodium citrate is used exclusively **in vitro** (e.g., in blood collection tubes and blood banks). It cannot be used in vivo because it would cause systemic hypocalcemia. * **Blood Transfusion:** Citrated blood used in massive transfusions can lead to **citrate toxicity**, resulting in hypocalcemia (manifesting as tetany or arrhythmias). * **Mechanism Distinction:** * **Chelators:** Citrate, EDTA (Ethylenediaminetetraacetic acid). * **Precipitants:** Oxalates. * **Antithrombin III Activator:** Heparin (the only one used both in vivo and in vitro).

Practice by Chapter

Composition and Functions of Blood

Practice Questions

Erythrocytes and Hemoglobin

Practice Questions

Leukocytes and Immune Function

Practice Questions

Platelets and Hemostasis

Practice Questions

Blood Groups and Transfusion

Practice Questions

Coagulation and Fibrinolysis

Practice Questions

Hematopoiesis

Practice Questions

Innate Immunity

Practice Questions

Adaptive Immunity

Practice Questions

Immunological Memory and Tolerance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free